Your browser doesn't support javascript.
loading
A new, improved and generalizable approach for the analysis of biological data generated by -omic platforms.
Pleasants, A B; Wake, G C; Shorten, P R; Hassell-Sweatman, C Z W; McLean, C A; Holbrook, J D; Gluckman, P D; Sheppard, A M.
Afiliación
  • Pleasants AB; 1Mathematical Biology Department,AgResearch,Hamilton,New Zealand.
  • Wake GC; 2Gravida National Centre for Growth and Development,Auckland,New Zealand.
  • Shorten PR; 1Mathematical Biology Department,AgResearch,Hamilton,New Zealand.
  • Hassell-Sweatman CZ; 4Liggins Institute,University of Auckland,Auckland,New Zealand.
  • McLean CA; 4Liggins Institute,University of Auckland,Auckland,New Zealand.
  • Holbrook JD; 5Singapore Institute for Clinical Sciences,National University of Singapore,Singapore.
  • Gluckman PD; 2Gravida National Centre for Growth and Development,Auckland,New Zealand.
  • Sheppard AM; 2Gravida National Centre for Growth and Development,Auckland,New Zealand.
J Dev Orig Health Dis ; 6(1): 17-26, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25335490
ABSTRACT
The principles embodied by the Developmental Origins of Health and Disease (DOHaD) view of 'life history' trajectory are increasingly underpinned by biological data arising from molecular-based epigenomic and transcriptomic studies. Although a number of 'omic' platforms are now routinely and widely used in biology and medicine, data generation is frequently confounded by a frequency distribution in the measurement error (an inherent feature of the chemistry and physics of the measurement process), which adversely affect the accuracy of estimation and thus, the inference of relationships to other biological measures such as phenotype. Based on empirical derived data, we have previously derived a probability density function to capture such errors and thus improve the confidence of estimation and inference based on such data. Here we use published open source data sets to calculate parameter values relevant to the most widely used epigenomic and transcriptomic technologies Then by using our own data sets, we illustrate the benefits of this approach by specific application, to measurement of DNA methylation in this instance, in cases where levels of methylation at specific genomic sites represents either (1) a response variable or (2) an independent variable. Further, we extend this formulation to consideration of the 'bivariate' case, in which the co-dependency of methylation levels at two distinct genomic sites is tested for biological significance. These tools not only allow greater accuracy of measurement and improved confidence of functional inference, but in the case of epigenomic data at least, also reveal otherwise cryptic information.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Perfilación de la Expresión Génica / Epigenómica Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Revista: J Dev Orig Health Dis Año: 2015 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Perfilación de la Expresión Génica / Epigenómica Tipo de estudio: Diagnostic_studies Límite: Animals Idioma: En Revista: J Dev Orig Health Dis Año: 2015 Tipo del documento: Article País de afiliación: Nueva Zelanda